Tirzepatide Dosing Guide: Schedule, Titration & What to Expect Each Week

Introduction

Tirzepatide for weight loss starts at 2.5 mg weekly and steps up every 4 weeks through 5, 7.5, 10, 12.5, and 15 mg. Maintenance can land at 10, 12.5, or 15 mg depending on response and tolerance. The titration takes 20 weeks to reach 15 mg if all steps are completed, longer than semaglutide’s 16-week schedule.

The slow ramp serves the same purpose as with semaglutide: acclimating gut and brain receptors so higher doses don’t trigger severe nausea. Going faster causes more dropouts and worse side effects. Some patients hold at lower doses if those produce adequate weight loss with better tolerance.

This guide covers each step in detail, what to expect at each level, how to handle missed or late doses, and when to slow the titration. Dosing for diabetes (Mounjaro®) and weight loss (Zepbound®) follows similar steps but with different maintenance targets.

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

What Is the Standard Tirzepatide Dosing Schedule?

The FDA-approved titration schedule for weight loss (Zepbound) is 2.5 mg weekly for 4 weeks, then 5 mg for 4 weeks, then 7.5 mg for 4 weeks, then 10 mg for 4 weeks, then 12.5 mg for 4 weeks, then 15 mg as a possible maintenance dose. The diabetes schedule (Mounjaro) follows similar steps.

Quick Answer: Standard titration: 2.5, 5, 7.5, 10, 12.5, 15 mg, 4 weeks per step

The starting dose of 2.5 mg is sub-therapeutic for weight loss. Its purpose is to acclimate the receptors. Most patients lose 2 to 4 pounds during this first month, but the bigger value is tolerating the climb.

Three maintenance doses are FDA-approved for weight loss: 5, 10, and 15 mg. Patients can stop titrating at 5 mg if response is adequate, or continue to 10 mg or 15 mg for greater effect. SURMOUNT-1 showed dose-response across these levels: 15% at 5 mg, 19.5% at 10 mg, 20.9% at 15 mg.

What Happens During Weeks 1 to 4 on 2.5 Mg?

Week 1 starts with the first 2.5 mg injection. Within 24 to 72 hours, most patients notice reduced hunger and earlier satiety with meals. Side effects show up in the same window: mild nausea, occasional reflux, fatigue. Most resolve by the end of week one.

Scale movement in week one is usually 2 to 4 pounds, partly water from reduced carb intake and the diuretic effect of lower insulin. Subsequent weeks usually show 1 to 2 pounds per week. By week 4, average loss is 2 to 4% of starting body weight.

Appetite suppression deepens over the 4 weeks. Cravings fade. Meals become smaller. Many patients report a noticeable change in food preference, with sweets and fried foods becoming less appealing. By week 4, most patients are at baseline tolerance and ready to step up to 5 mg.

What Changes at 5 Mg (Weeks 5 to 8)?

The step to 5 mg doubles the dose. About 30 to 40% of patients see a fresh wave of mild nausea or GI side effects in the first 1 to 2 weeks after the increase. The body habituates again.

Appetite suppression becomes much more obvious at 5 mg. Meals shrink substantially. Many patients report eating only because they remember they should. Weight loss accelerates to 1.5 to 2.5 pounds per week.

By the end of week 8, average loss is around 5 to 7% of starting body weight. Some patients with strong response at 5 mg consider holding rather than continuing to titrate. This is reasonable if loss is on track and side effects are tolerable. Many clinicians prefer continuing to titrate at the standard pace.

What’s Different About 7.5 Mg (Weeks 9 to 12)?

The 7.5 mg dose is intermediate between starting and high-dose tirzepatide. Side effects sometimes pick up again with the step from 5 to 7.5 mg, particularly nausea after fatty meals. Hydration matters more at this dose.

Many patients see their fastest weekly losses at 7.5 mg, often 2 to 3 pounds per week. Average cumulative loss by week 12 is 7 to 10% of starting body weight. Energy levels usually feel normal by this point because the body has adapted to lower intake.

Constipation can become more pronounced at 7.5 mg. Fiber, hydration, and increased physical activity usually fix it within a week. Magnesium citrate or polyethylene glycol (MiraLAX) is sometimes added.

What’s the 10 Mg STEP (Weeks 13 to 16) Like?

The 10 mg step often produces another small wave of side effects, especially for patients who had mild symptoms at lower doses. Hunger essentially disappears for most patients at 10 mg. Food doesn’t sound interesting.

By the end of week 16, average loss is 10 to 13% of starting body weight. SURMOUNT-1 maintenance at 10 mg produced 19.5% loss at 72 weeks, very close to the 20.9% on 15 mg. For many patients, 10 mg is a reasonable maintenance dose with better tolerability than 15 mg.

This is often the decision point for whether to continue to 12.5 and 15 mg or hold at 10 mg. The risk-benefit weighs side effect tolerance against the small added weight loss benefit at higher doses.

What About 12.5 and 15 Mg?

The 12.5 mg dose is a stepping stone to 15 mg, used for 4 weeks before the final increase. Side effects at 12.5 mg vary. Some patients tolerate it well, others find the GI effects increase noticeably.

The 15 mg maintenance dose produced 20.9% mean weight loss at 72 weeks in SURMOUNT-1. The dose is FDA-approved as a maintenance dose for weight loss. Continued weight loss happens through about month 15 to 18 at this dose.

Some patients stay at 15 mg long-term. Others step back down to 10 mg or 12.5 mg after reaching their target weight to reduce side effects while holding the loss. There’s no head-to-head trial of maintenance levels, but observational data support lower doses for maintenance.

How Do You Handle Missed or Late Doses?

FDA labeling for tirzepatide says: if the missed dose is within 4 days of the scheduled day, take it as soon as remembered and continue on the normal schedule. If more than 4 days have passed, skip and resume on the next scheduled day.

This is slightly shorter than the 5-day window for semaglutide, reflecting tirzepatide’s slightly shorter half-life (5 vs 7 days). Two or more consecutive missed doses can require titration back down, especially if at 10 mg or higher.

If traveling and needing to shift the weekly day, the dose can be moved up to 2 days earlier or later without issue. Larger shifts should be staggered over a few weeks.

Key Takeaway: Total titration to 15 mg takes 20 weeks

When Should You Slow or Pause the Titration?

Most clinicians pause titration when nausea or vomiting interferes with daily function, when hydration is hard to maintain, when fasting glucose drops below 70 mg/dL repeatedly in diabetic patients, or when alarm symptoms develop.

A common pattern is staying at the current dose for an extra 2 to 4 weeks. The body almost always catches up. Permanent maintenance at 5, 7.5, or 10 mg is fine if the patient is losing weight and feels good.

Pancreatitis symptoms (severe persistent upper abdominal pain) require stopping immediately and getting evaluated. Gallbladder pain after rapid weight loss is another reason to call your clinician.

What’s the Dosing Approach for Diabetes (Mounjaro)?

Mounjaro for type 2 diabetes uses the same titration schedule, though maintenance often lands at lower doses than for weight loss. Many diabetic patients reach adequate HbA1c control at 5, 7.5, or 10 mg without needing 15 mg.

Some clinicians titrate based on glucose targets rather than scheduled steps. A patient who reaches HbA1c target at 7.5 mg may hold there rather than continuing to escalate. The added weight loss benefit at higher doses is balanced against side effect risk.

For patients with both diabetes and obesity, the higher Zepbound doses are sometimes used to drive both glucose control and weight loss. Insurance coverage decisions sometimes determine which label is used.

Does Dose Timing Affect Side Effects?

Most patients inject in the evening so any same-day nausea passes during sleep. There’s no clinical reason to favor morning vs evening. Some people prefer dosing on a Friday or Saturday so peak nausea risk (24 to 48 hours later) falls on a weekend.

Rotating injection sites between abdomen, thigh, and upper arm reduces local skin reactions. There’s no meaningful difference in absorption between sites. Pinch the skin, inject at a 90-degree angle, and hold for a count of five.

Taking the dose with food vs fasted doesn’t matter pharmacokinetically because subcutaneous absorption is slow regardless. Some patients prefer dosing on an empty stomach to avoid associating the injection with a heavy meal.

How Does Compounded Tirzepatide Dosing Differ?

Compounded tirzepatide contains the same active molecule as Mounjaro and Zepbound. The dosing schedule mirrors brand: 2.5, 5, 7.5, 10, 12.5, 15 mg weekly with 4 weeks per step.

Compounded pharmacies often dispense multi-dose vials. The patient draws their dose into a syringe. This requires understanding unit-to-milligram conversions and proper injection technique. TrimRx provides a personalized treatment plan with clear written dosing instructions and an option for compounded delivery.

Some compounded preparations have different concentrations than the brand pen markings. Follow the new pharmacy’s specific instructions rather than the brand pen dose markings.

What About Plateaus During Titration?

Most patients hit a 1 to 3 week plateau somewhere in the middle of the titration. This is normal. The body adjusts hormonally, water shifts back, and the scale stalls before resuming the downward trend.

The temptation is to jump to the next dose early. That usually backfires with more side effects. The better approach is holding the schedule and giving the plateau 2 to 3 weeks to resolve. Resistance training during a plateau helps preserve lean mass and resumes loss.

If a plateau lasts beyond 4 weeks on a given dose, the dose step typically breaks it. The mid-titration plateau is different from the long-term plateau at month 15 to 18, which represents the body’s new energy balance equilibrium.

Bottom line: Average weight loss at week 20: 8 to 12% of starting body weight

FAQ

Can I Skip the 2.5 Mg Starting Dose?

No. The starting dose acclimates the gut and brain receptors. Skipping increases the rate of severe nausea, vomiting, and treatment discontinuation. Even for patients with prior GLP-1 experience, restarting at 2.5 mg after any gap longer than 2 weeks is standard.

How Long Can I Stay at 5 or 7.5 Mg If It’s Working?

There’s no strict time limit. If weight loss is on track and side effects are manageable, staying at 5 or 7.5 mg is reasonable. Many clinicians prefer the lowest effective dose. The drug works at all therapeutic levels, just with different ceilings.

Should I Aim for 15 Mg Specifically?

Not necessarily. SURMOUNT-1 showed 19.5% loss at 10 mg vs 20.9% at 15 mg. The added benefit at 15 mg is small for many patients. If 10 mg is producing good loss with tolerable side effects, holding there is fine.

What If I Gain Weight During Titration?

Brief gains during the first 1 to 2 weeks of a new dose can happen due to water shifts or constipation. If gain persists beyond 3 weeks, evaluate dietary changes, hydration, sleep, and alcohol. Genuine weight gain on a titrating dose is uncommon if intake and activity haven’t changed.

Can I Dose More Than Once a Week?

No. Twice-weekly dosing has not been studied and would raise plasma levels above the safety profile of weekly dosing. The half-life is designed for weekly injection.

What If I Run Out of Medication Before Refill?

Try to coordinate refills 5 to 7 days before finishing your current vial or pen. If you run out for a week or more, contact your provider before resuming. Brief gaps usually allow continuing at the same dose. Gaps over 2 weeks often require restarting at a lower step.

Is There a Maximum Lifetime Dose?

No. Tirzepatide has been studied for over 5 years of continuous use without signs of cumulative toxicity. Long-term safety data continue to accrue through ongoing trials and registry studies. As long as the drug is working and side effects are tolerable, indefinite use is appropriate.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.